NEW YORK (GenomeWeb) – Bruker announced today that its board of directors has approved a new $225 million share repurchase program.

The firm said the repurchase program commenced yesterday and will run for two years. During that time Bruker may repurchase its common stock from time to time in amounts and at prices that it deems appropriate. It added that the repurchases may be made on the open market, privately negotiated, or through other transactions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.